Showing results (1271-1280 of 1,842) with videos related to
Sort By:
Pageof 185
Journal of Managed Care & Specialty Pharmacy|January 17, 2025
Comparing demographic/clinical characteristics, health care resource utilization, and costs among patients with type 2 diabetes and established atherosclerotic cardiovascular disease with and without the use of cardioprotective medicationsTyler J Dunn, Yiwen Cao, Lin Xie, et al.Journal of Managed Care & Specialty Pharmacy|February 28, 2025
Use of health technology assessments in specialty drug coverage decisions by US commercial health plansDaniel E Enright, Emma G van Duijnhoven, Daniel A Ollendorf, et al.Journal of Managed Care & Specialty Pharmacy|September 2, 2024
Multidisciplinary perspectives in Demodex blepharitis: A new view of treatment from clinical, payer, and patient perspectivesMichael R PageJournal of Managed Care & Specialty Pharmacy|September 11, 2024
Impact of next-generation sequencing vs polymerase chain reaction testing on payer costs and clinical outcomes throughout the treatment journeys of patients with metastatic non-small cell lung cancerChristine M Bestvina, Dexter Waters, Laura Morrison, et al.Journal of Managed Care & Specialty Pharmacy|August 30, 2024
Real-world effectiveness and safety of advanced therapies for the treatment of moderate-to-severe ulcerative colitis: Evidence from a systematic literature reviewPeter M Irving, Peter Hur, Raju Gautam, et al.Journal of Managed Care & Specialty Pharmacy|August 30, 2024
Nonalcoholic steatohepatitis/metabolic dysfunction-associated steatohepatitis emerging market: Preparing managed care for early intervention, equitable access, and integrating the patient perspectiveBridget FlavinJournal of Managed Care & Specialty Pharmacy|August 30, 2024
Development of stakeholder-informed recommendations for inclusion of family spillover effects in health technology assessmentDavid J Campbell, Rajshree Pandey, Lisa M Bloudek, et al.Journal of Managed Care & Specialty Pharmacy|August 30, 2024
Patient liability, treatment adherence, and treatment persistence associated with state bans of copay accumulator adjustment programsAchal Patel, Danny Sheinson, William B WongJournal of Managed Care & Specialty Pharmacy|October 29, 2024
Patient-reported disability progression outcomes among patients with multiple sclerosis: Results of an outcomes-based agreementElizabeth C S Swart, Samuel K Peasah, Jacqueline Alderson, et al.Journal of Managed Care & Specialty Pharmacy|October 29, 2024
Potential benefits of incorporating social determinants of health screening on comprehensive medication management effectivenessJoel F Farley, Swetha PradeepPageof 185